A Pilot Study to Test the Effect of Treating Depression Associated with Rueumatoid Arthritis (RA) using Venlaflaxine - Venlaflaxine & Numact Study
- Conditions
- Symptoms of Depression as defined by the Hospital Anxiety and Depression Questionnaire associated with Rheumatoid Arthritis
- Registration Number
- EUCTR2004-002482-20-GB
- Lead Sponsor
- ewcastle upon Tyne Hospitals NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
Rheumatoid Arthritis(ACR criteria)
Male or Female Aged 18 years or over.
Female patients of childbearing potential must be using an adequate and reliable method of contraception whilst taking Venlaflaxine.
Willing and able to provide written informed consent.
Functional classification of II or III (ACR criteria)
A score > 10 on the Hospital anxiety and Depression score
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Previously Diagnosed Depression
Other physically disabling condition/concomitant chronic disease
Contraindicated use of Venlaflaxine
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method